Presbyopia Completed Phase 2 Trials for Aceclidine (DB13262)

Also known as: Presbyopias

IndicationStatusPhase
DBCOND0001183 (Presbyopia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03201562A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate PresbyopiaTreatment